Researchers create a Layout schema for navigation technologies to Assist Individuals with disabilities Kumar Jeetendra | August 16, 2020 Although studies about assistive navigation and technologies are becoming more popular in recent decades, the researchers assert that current studies have been too narrow in its perspective of people with disabilities. For this particular study, researchers worked with technology users with a broad and diverse range of disabilities to discover similarities and differences in their …
Coronavirus vaccine Offender in China Reveals immune Reaction, enters Stage 3 trial Kumar Jeetendra | August 16, 2020 An vaccine candidate against the publication coronavirus or SARS-Cov-2, developed by Sinopharm, has demonstrated promising effects in immune reaction trials, researchers assert. The vaccine candidate is apparently secure and have triggered antibody-based immune reaction in ancient and mid-stage trials and has been moved into late-stage trials for regulatory acceptance, the Hindustan Times reported. According to …
In procedure of acquiring natural freedom for new plant in Madhya Pradesh: Ipca Labs Kumar Jeetendra | August 16, 2020 New Delhi, Aug 16 (PTI) Medicine manufacturer Ipca Laboratories is in the process of getting environmental clearance for a new production plant in Dewas, Madhya Pradesh, according to its 2019-20 annual report. Sharing information with the firm”s shareholders, the drug maker said the company has already acquired land to the job. “The organization is in …
USFDA clears basic salivation test for quicker identification of COVID-19 Kumar Jeetendra | August 16, 2020 Houston, Aug 16 (PTI) The US health watchdog has authorised the emergency use of some new and expensive saliva established laboratory diagnostic test for COVID-19 which might be a game changer in the identification of the infection because it will enable rapid testing among more people easily. Stephen Hahn, the Food and Drugs Administration Commissioner, …
COVID-19 virus mutation that is ’10 times’ more irresistible recognized in Malaysia Kumar Jeetendra | August 17, 2020 KUALA LUMPUR: A mutation of this COVID-19 virus that is”10 times” more infectious was detected in Malaysia. The state’s Health Ministry director-general Noor Hisham Abdullah said the neighborhood needed to be careful, after a D614G mutation of the novel coronavirus was discovered. “It’s is found to be 10 times easier to infect different people and …
Vaccine firm Biological E gains Akorn’s injectable plant in India for $10 million Kumar Jeetendra | August 17, 2020 Vaccine maker Biological E (BE), on August 17 stated it has acquired Akorn India, a subsidiary of US-based Akorn which generates speciality generic injectable medicines and vaccines for around $10 million in money. BE said the acquisition will allow the Hyderabad-based organization to boost its manufacturing capabilities and abilities to produce and furnish its vaccines …
Blend of nanotechnology and hereditary designing for managing lethal malignant growth stemness Kumar Jeetendra | August 17, 2020 The development of chemotherapeutic agents with discerning anti-cancer actions is unattractive due to the emergence of resistance, inadequate targeting of cancer tissues, and subsequent metastasis. One of tumor attribute cellular types, cancer stem cells have become associated with cancer development and metastasis, representing self-renewal and their propensity to join the flow. Scientists at Japan Advanced …
DBT/BIRAC Supported Rapid test for COVID antibody detection: 100% Indigenous Kumar Jeetendra | August 17, 2020 Delhi based Oscar Medicare Pvt. Ltd., manufacturer of various in-vitro diagnostic kits, has developed a rapid test for detection of COVID antibody using recombinant proteins of 100% Indian origin in collaboration with Dhiti Life Sciences Pvt. Ltd. (DLSPL). The product has been validated and approved by ICMR lab-National Institute of Virology-Pune. As per ICMR report, …
Eight groups of researchers from India and US chose for seeking after exploration on COVID-19 Kumar Jeetendra | August 19, 2020 Eight binational groups of researchers from India and the US are chosen for following cutting-edge study in pathogenesis and disease control of COVID-19, based on an official announcement on Tuesday. The teams will pursue research in areas such as anti fungal coatings, and immune modulation, tracking SARS CoV-2 from wastewaterand illness detection mechanics, reverse genetics …
WHO boss Tedros Adhanom Ghebreyesus calls for end to ‘immunization patriotism’ Kumar Jeetendra | August 19, 2020 The World Health Organization’s (WHO) chief Tedros Adhanom Ghebreyesus stated on August 18 that nations placing their own interests ahead of the others in trying to make sure supplies of a potential coronavirus vaccine are creating the pandemic worse. “(Acting) strategically and globally is in fact in each country’s national interest – no one is …
Coronavirus immunization will be prepared by December-end, says Chinese organization SinoPharm Kumar Jeetendra | August 19, 2020 The head of a major state-owned Chinese pharmaceutical company explained its coronavirus vaccine will be commercially available at the end of the year. Liu Jingzhen, ” the chairman of SinoPharm, advised that a Chinese Communist Party newspaper that the vaccine would cost less than 1,000 yuan ($140) and be awarded in two shots, 28 weeks …
Dr Reddy’s dispatches Avigan (Favipiravir) tablets in India Kumar Jeetendra | August 19, 2020 Dr Reddy’s Laboratories on August 19 announced the launch of Avigan (Favipiravir) pills, used for treating mild to moderate COVID-19 sufferers in India. Dr Reddy’s stated Avigan was approved by the Drugs Controller General of India (DCGI) for treating patients with moderate to medium COVID-19. “The need for high efficacy and quality, affordability and improved …
